secwatch / observer
8-K filed November 29, 2022, 6:59 PM ET ticker ABBV CIK 0001551152
leadership confidence high sentiment neutral materiality 0.30

AbbVie CFO promoted to EVP; Controller Durkin to retire, Buckbee named successor

AbbVie Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Kevin K. Buckbee

Senior Vice President, Controller
ABBV · AbbVie Inc.
Effective
2023-03-01
Filed
November 29, 2022, 6:59 PM ET
Kevin K. Buckbee, 57, has been appointed Senior Vice President, Controller effective March 1, 2023.
Departed

Brian L. Durkin

Vice President, Controller
ABBV · AbbVie Inc.
Effective
2023-03-01
Successor
Kevin K. Buckbee
Filed
November 29, 2022, 6:59 PM ET
On November 28, 2022, Brian L. Durkin, Vice President, Controller, informed AbbVie that he plans to retire from the Controller role effective March 1, 2023.
Role change

Scott T. Reents

Executive Vice President, Chief Financial Officer
ABBV · AbbVie Inc.
Effective
2022-11-29
Filed
November 29, 2022, 6:59 PM ET
Scott T. Reents, Senior Vice President, Chief Financial Officer, has been appointed Executive Vice President, Chief Financial Officer, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Kevin K. Buckbee was appointed as Senior Vice President, Controller at AbbVie Inc..

Action
appointed
Role
Senior Vice President, Controller
Exact text from the filing
Kevin K. Buckbee, 57, has been appointed Senior Vice President, Controller effective March 1, 2023.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Brian L. Durkin departed as Vice President, Controller at AbbVie Inc..

Action
retire
Role
Vice President, Controller
Exact text from the filing
On November 28, 2022, Brian L. Durkin, Vice President, Controller, informed AbbVie that he plans to retire from the Controller role effective March 1, 2023.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Scott T. Reents was appointed as Executive Vice President, Chief Financial Officer at AbbVie Inc..

Action
appointed
Role
Executive Vice President, Chief Financial Officer
Exact text from the filing
Scott T. Reents, Senior Vice President, Chief Financial Officer, has been appointed Executive Vice President, Chief Financial Officer, effective immediately.
View on SEC.gov

AbbVie Inc. filing history →

Source: SEC EDGAR
accession 0001104659-22-122661
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.